Merck & Co., Inc.
Close on Oct 30, 2026Market cap $368.89BP/E 119.6Yield 2.19%
Merck Vytorin by Quarter
Vytorin (ezetimibe/simvastatin, legacy pre-Organon spin-off) — U.S. reported growth YoY (%) (%)
Merck Vytorin: -29.0% in Q1 2021, down 47.0 pts from a year earlier. No newer figure appears in the documents we track.
Where the Q1 2021 figure comes from
“|| Vytorin | 41 | 53 | -23 | 2 | 3 | -29 | 38 | 50 | -23”
Source: Form 8-K (tm2114316d1_ex99-1.htm, filed 2021-04-29) ↗
Reported in Form 8-K Table 3a / 3b Product Sales.
Quarterly history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Vytorin (ezetimibe/simvastatin, legacy pre-Organon spin-off) — U.S. reported growth YoY (%) (%) | Year on year | Source |
|---|---|---|---|---|
| Q1 2021 | Mar 31, 2021 | -29.0% | -47.0 pts | Form 8-K (tm2114316d1_ex99-1.htm, filed 2021-04-29) ↗ |
| Q3 2020 | Sep 30, 2020 | -34.0% | – | Form 8-K (tm2032785d1_ex99-1.htm, filed 2020-10-27) ↗ |
| Q2 2020 | Jun 30, 2020 | -42.0% | -70.0 pts | Form 8-K (tm2026006d1_ex99-1.htm, filed 2020-07-31) ↗ |
| Q1 2020 | Mar 31, 2020 | 18.0% | +82.0 pts | Form 8-K (tm2016917d1_ex99-1.htm, filed 2020-04-28) ↗ |
| Q2 2019 | Jun 30, 2019 | 28.0% | +119.0 pts | Form 8-K (a19-15283_1ex99d1.htm, filed 2019-07-30) ↗ |
| Q1 2019 | Mar 31, 2019 | -64.0% | +27.0 pts | Form 8-K (a19-8996_1ex99d1.htm, filed 2019-04-30) ↗ |
| Q4 2018 | Dec 31, 2018 | -109.0% | -17.0 pts | Form 8-K (a19-3795_1ex99d1.htm, filed 2019-02-01) ↗ |
| Q2 2018 | Jun 30, 2018 | -91.0% | – | Form 8-K (a18-17779_1ex99d1.htm, filed 2018-07-27) ↗ |
| Q1 2018 | Mar 31, 2018 | -91.0% | – | Form 8-K (a18-12417_1ex99d1.htm, filed 2018-05-01) ↗ |
| Q4 2017 | Dec 31, 2017 | -92.0% | – | Form 8-K (a18-5152_1ex99d1.htm, filed 2018-02-02) ↗ |
Cite this data
StockData. (2026). Merck Vytorin (%), quarterly Q4 2017–Q1 2021 [Data set]. Compiled from Merck SEC filings and investor materials. https://stockdatahq.com/stocks/mrk/kpis/rev-vytorin-us-nom-yoy
See every metric in the Merck KPI table. Data updated Oct 26, 2026.